One Step Closer to a Plan

Happy Friday!  As promised, I wanted to provide an update before the weekend.

My latest MRI results show:

• The original cavities of Tumor # 1 and Tumor # 2 from my two craniotomies remain clear.
• The radiation from my gamma knife in January continues to eliminate Tumor # 3 and Tumor # 4.
• There was no increase in the size of Tumor #5 (which dramatically decreased in size during the first cycle of Vemurafenib).
• Two new tumors have been identified.

 Given the presence of two new tumors, the KMA team has been conferring over the last few days to determine the following:

1. Can I remain in the Vemurafenib clinical trial?
2. What is the recommended treatment plan for the new tumors?

 I received terrific news regarding Question 1.  Dr. Flaherty obtained approval from Hoffman La-Roche (the drug manufacturer) for me to remain in the study.  Despite the fact there are 2 new tumors, the Vemurafenib is still working for me in some respects.

• As noted above, Tumor #5 has held steady during the second cycle.
• The first cycle of the drug significantly reduced Tumor # 5 (by more than 50%).
• Additionally, it is resolving the mass in my right lower lung which was identified last August.

Keith & I will be at Karmanos Monday morning to answer Question #2.  We have an appointment with Dr. Mittal (my neurosurgeon) to review his recommended treatment plan that was formulated with Dr. Flaherty's input. 

I am beyond grateful that I get to stay in the study. It is such a relief as the drug is exorbitantly expensive.

Stay tuned for a report on how we intend to show the cancer who is really the boss!